Clinical trial
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are…
NCT00495469 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00495469 |
|---|---|
| Title | Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive |
| Official title | A Once-Daily Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment-Naïve Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | GSK189075, Placebo |
| Enrollment | 250 |
| Start date | Aug 17, 2007 |
| Primary completion | Jun 5, 2008 |
| Completion | Jun 5, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | Oct 30, 2017 |
| Countries | Canada, Czechia, Estonia, Germany, Greece, India, Lithuania, Mexico, New Zealand, Poland, Puerto Rico, Romania and 4 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: